Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Equashield

Explore full profile

A privately held medical device company that provides closed system transfer device for safe handling of hazardous drugs

Town of North Hempstead, United StatesFounded 2009Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2022
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Equashield and the history behind them.

About Equashield

Equashield is a leading provider of closed system drug transfer devices (CSTDs) designed to ensure the safety and efficiency of healthcare professionals who handle hazardous drugs. The company serves a diverse range of clients including pharmacists, nurses, hospitals, and veterinarians, operating primarily in the healthcare and veterinary markets. Equashield's business model revolves around the development and sale of meticulously engineered compounding solutions that prevent exposure to hazardous drugs, thereby protecting healthcare workers and patients alike. Revenue is generated through the direct sale of these innovative products, which include needle-safe syringes, encapsulated syringes with pressure equalization systems, and other safety components. The company's solutions are backed by peer-reviewed studies and are designed with the end user in mind, ensuring ease of use and maximum safety. Equashield's market presence is bolstered by its commitment to quality, innovation, and the well-being of the 8 million healthcare professionals it aims to protect.

Source: Dealroom company data

At a glance

Founded
2009
Headquarters
Town of North Hempstead, United States
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Nordic Capital
Employees mapped 138 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 22 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇮🇱 Israel52.2%
🇺🇸 United States41.3%
🇧🇪 Belgium3.3%
🇹🇭 Thailand1.1%
🇩🇪 Germany1.1%
Top 5 of 6 shown

Patents

Estimated portfolio value
$47M

32 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Equashield on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Equashield on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.